Advanced Pharma Inc. is recalling approximately 160 syringes of HEPERAIN (Heparin Sodium) 50 mg/50 mL (1mg/mL) Injectable Solution. The recall was initiated because the product labels incorrectly state the concentration as 50 mg/50 mL (1 mg/mL) when the actual, accurate concentration is 50 Units/50 mL (1 Unit/mL). This mislabeling affects product with lot number 12/19/18 0242 72565S and was distributed to facilities in Texas and Washington. Consumers and healthcare providers should check their inventory immediately for this specific lot.
The discrepancy between 'mg' and 'Units' on the medication label can lead to significant dosing errors. If a healthcare provider administers the drug based on the incorrect concentration listed on the label, the patient may receive an improper dose of Heparin, potentially leading to ineffective treatment or adverse health consequences.
Return for refund and contact healthcare provider.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.